Review: Oral drugs for type 2 diabetes, alone or in combination, have different relative benefits and harms for surrogate endpoints

W. L. Bennett

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Review: Oral drugs for type 2 diabetes, alone or in combination, have different relative benefits and harms for surrogate endpoints'. Together they form a unique fingerprint.